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Adult myogenesisIdentifying the genetic program that leads to formation of functionally and morphologically distinct muscle
ﬁbers is one of the major challenges in developmental biology. In Drosophila, the Myocyte Enhancer
Factor-2 (MEF2) transcription factor is important for all types of embryonic muscle differentiation. In this
study we investigated the role of MEF2 at different stages of adult skeletal muscle formation, where a diverse
group of specialized muscles arises. Through stage- and tissue-speciﬁc expression of Mef2 RNAi constructs,
we demonstrate that MEF2 is critical at the early stages of adult myoblast fusion: mutant myoblasts are
attracted normally to their founder cell targets, but are unable to fuse to form myotubes. Interestingly, abla-
tion of Mef2 expression at later stages of development showed MEF2 to be more dispensable for structural
gene expression: after myoblast fusion, Mef2 knockdown did not interrupt expression of major structural
gene transcripts, and myoﬁbrils were formed. However, the MEF2-depleted ﬁbers showed impaired integrity
and a lack of ﬁbrillar organization. When Mef2 RNAi was induced in muscles following eclosion, we found
no adverse effects of attenuatingMef2 function. We conclude that in the context of adult myogenesis, MEF2
remains an essential factor, participating in control of myoblast fusion, and myoﬁbrillogenesis in develop-
ing myotubes. However, MEF2 does not show a major requirement in the maintenance of muscle structural
gene expression. Our ﬁndings point to the importance of a diversity of regulatory factors that are required
for the formation and function of the distinct muscle ﬁbers found in animals.
© 2011 Elsevier Inc. All rights reserved.Introduction
Studying myogenesis in model organisms provides insights into
the genetic causes of human muscular diseases, as divergent species
are thought to utilize similar strategies in muscle development and
maintenance. Drosophila melanogaster has long been used as a tool in
dissecting genetic and molecular mechanisms of muscle development.
Development of somatic muscles in Drosophila occurs at two
stages of the life cycle. First, during the embryonic phase, all muscle
types arise from the mesoderm via an intense burst of cell speciﬁ-
cation and tissue-type differentiation. Fusion of numerous fusion-
competent myoblasts to individual founder cells creates multi-nucleate
myoﬁbers that elongate and adhere to designated cuticular attachment
sites (Baylies andMichelson, 2001; Beckett and Baylies, 2006; Dohrmann
et al., 1990). Following fusion, nascent myoﬁbers activate the expression
of muscle structural genes, and the larval somatic muscles activate a
relatively uniform set of these genes: the muscles invariably express
the embryonic muscle actin gene, Act57B (Kelly et al., 2002); as well
as the troponin C gene TpnC73F (with other troponin C gene products
being non-detectable by hybridization in situ (Herranz et al., 2004)),rights reserved.and other muscle structural genes (Arredondo et al., 2001; Gasch et
al., 1988; Zhang and Bernstein, 2001). Hence, at the end of embryonic
myogenesis, somatic muscles appear as arrays of individual myoﬁbers,
arranged in a largely consistent pattern in eachbody segment, and shar-
ing a relatively uniform expression of muscle structural genes.
There is compelling evidence that the MADS domain transcription
factor Myocyte Enhancer Factor-2 (MEF2) plays an essential role at
the embryonic stage of muscle development. Although speciﬁcation
of muscle precursors proceeds normally in aMef2mutant background,
these mutants show a profound lack of multinucleate myotubes (Bour
et al., 1995; Lilly et al., 1995; Paululat et al., 1999; Ranganayakulu et
al., 1995). Consistent with this observation, many structural muscle
genes have functional MEF2-binding sites in their enhancers (Kelly et
al., 2002; Lin et al., 1996; Sandmann et al., 2006; Tanaka et al., 2008).
Drosophila MEF2 is a transcriptional activator, capable of initiating
expression of these target genes autonomously, even in foreign envi-
ronments such as the embryonic ectoderm or S2 cells in tissue cul-
ture (Lin et al., 1997a; Tanaka et al., 2008).
At the second phase of Drosophila myogenesis, that occurs during
pupal development, pre-existing larval muscles become histolyzed and
adult muscles develop de novo. Adult myoﬁbers arise from adult muscle
precursor myoblasts, that have been preserved throughout the larval
stage as small clusters of cells associated with the nerves and imaginal
discs (Dutta et al., 2004; Rivlin et al., 2000). During metamorphosis,
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(Currie and Bate, 1991; Fernandes et al., 1991; Roy and VijayRaghavan,
1997), where myoblast fusion is initiated by sparse founder cells that
play essentially the same roles as in embryogenesis (Dutta et al., 2004;
Rivlin et al., 2000). In one speciﬁc case, being the formation of the
adult dorsal longitudinal indirect ﬂight muscles, the role of founder
cells is taken by a subset of persistent larval myoﬁbers (Fernandes et
al., 1991). Following fusion, newly-developed myoﬁbers enter the hy-
pertrophic phase of growth, where the muscle volume increases due
to massive expression of structural genes and assembly of the contrac-
tile apparatus.
While superﬁcially the process of adult skeletal myogenesis appears
analogous to muscle development in the embryo, muscle formation in
adults results in signiﬁcantly more diverse groups of myoﬁbers, due to
the appearance of new specialized muscles. Specialized somatic mus-
cles in adult ﬂies include the indirect ﬂight muscles (IFMs), the tergal
depressor of the trochanter (TDT, or jumpmuscle), direct ﬂightmuscles
at the base of thewing, aswell as head and legmuscles (Bernstein et al.,
1993). Muscles in adults that resemble the relatively uniform larval
muscle type are restricted to the abdominal body wall (Baker et al.,
2005; Currie and Bate, 1991). Clearly, adult myogenesis in Drosophila
shows both similarities and differences with embryonic muscle devel-
opment: speciﬁcation of founder cells, myoblast fusion, and muscle
differentiation are common processes; on the other hand, adult mus-
cles are highly divergent from embryonic muscles in size, arrangement,
ultrastructure, and physiology (reviewed in Bernstein et al., 1993).
The broad spectrum of specialized adult muscles correlates with
the distinct and speciﬁc functions that they perform. For example,
the most prominent thoracic muscles, the TDTs and IFMs, generate
power for jumping and ﬂying, respectively, and their different behav-
ioral functions are correlated with these muscles having different
morphological characteristics (see Peckham et al., 1990). Based upon
their ultrastructure, the IFMs belong to the ﬁbrillar type of muscles,
whereas the TDTs are of a tubular type, reﬂecting the architecture and
organization of their myoﬁbrils. These muscles are different at the mo-
lecular level, too: IFMs express the muscle-speciﬁc actin gene Act88F,
and the troponin C gene TpnC41F; while TDTs express Act79B and
TpnC41C (Fyrberg et al., 1983; Herranz et al., 2004). The Act57B and
TpnC73F genes, expressed in all embryonic and larval skeletal muscles,
show strong restriction in expression at the adult stage, to the abdomi-
nal body wall muscles (Baker et al., 2005; Herranz et al., 2004). Never-
theless, somemuscle-speciﬁc genes retain their persistent expression in
all adult muscles, including theMyosin heavy chain (Mhc) gene (Hess et
al., 2007). Altogether, the understanding of how transcriptional regula-
tion is controlled in somaticmuscles during the transition from larval to
adult musculature – allowing activation of some new genes and shut-
ting down other ones, while keeping some genes active all along – has
become a major research question.
The role of MEF2 in adult myogenesis remains obscure. Our labora-
tory previously assessed the role of MEF2 in adult myogenesis using
Mef2 temperature-sensitive alleles (Baker et al., 2005). The results of
our study revealed that Mef2 down-regulation caused relatively mild
defects in adult muscle formation, in remarkable contrast to the severe
muscle defects observed in embryos under similar experimental condi-
tions. The weak adult phenotype was also demonstrated in earlier
studies that employed different Mef2 hypomorphic mutants (Nguyen
et al., 2002; Ranganayakulu et al., 1995). Thus, it was suggested that
the requirement for MEF2 function in adult myogenesis is somewhat
reduced. However, it was still clear that both the hypomorphic and
temperature-sensitive mutants retained some small MEF2 function,
and we speciﬁcally raised the possibility that low levels of residual
MEF2 function were still sufﬁcient to support myogenesis. It remained
to be determined how a more exacerbated effect upon MEF2 activity
might impact adult myogenesis.
In this study, we have taken an RNAi approach to knockdownMef2
function in the developing adult muscles, at various steps of adultmyogenesis. We ﬁnd that silencing of Mef2 in adult myoblasts leads
to a massive loss of somatic muscles, due to inability of the myoblasts
to fuse, to activate expression of muscle genes, and to generate myo-
ﬁbers. By contrast, silencing of Mef2 in post-fusion myoﬁbers has less
dramatic effects on ﬁbrillogenesis and expression of structural muscle
genes. Finally, silencing of Mef2 in post-eclosion muscles does not
produce a detectable deleterious effect on muscular structure and
performance during adult life. We conclude that, in adult muscles,
MEF2 remains a critical factor for myoblast fusion and initiation of
muscle structural gene expression. However, MEF2 becomes less es-
sential for the maintenance of structural gene expression, and its
role is taken by other factors. Our study provides new data for under-
standing the developmental program necessary for formation of di-
vergent, specialized groups of muscles such as those that are found
in higher animals.
Materials and methods
Molecular cloning
The cloning of the Mef2 inverted repeat (IR) construct was done
following the strategy described before (Bao and Cagan, 2006). An
approximately 700-bp region of the Mef2 coding sequence, present
in all annotated Mef2 transcripts (Fig. 1A), was ampliﬁed using the
forward 5′-ACTCTAGACCACCATTTGTCCATTAAGCA and the reverse
5′-GTTCTAGACTGGAGTGGGTGTGATGTGG primers. The underlined re-
gions in the primer sequences are non-genomic sequence, added to
achieve cleavage of the PCR product with XbaI. Amplicons digested
with XbaI and thereby containing the CTAG overhangs at each end,
were cloned into the vector pGEM-WIZ (obtained from the Drosophila
Genomic Resource Center (DGRC), IN, USA) via the end-compatible
AvrII restriction site. The orientation of the insert was veriﬁed by analyt-
ical restriction digest. In the second round of cloning, the same XbaI-
treated ampliconswere inserted into the pGEM-WIZ already containing
one sense-oriented amplicon, via the XbaI restriction site, and the
resulting clones were screened for those bearing tail-to-tail amplicon
insertions, separated by a short intron provided by the vector. Selected
clones were veriﬁed by direct sequencing. Next, the whole construct,
containing the two amplicons separated by the intron, was cut out of
the pGEM-WIZwith SpeI and inserted into pUAST (Brand and Perrimon,
1993) via compatible ends produced by digesting pUAST with XbaI.
The ﬁnal construct, pUAST-C–Mef2–IR(2), or IR2, was veriﬁed by
sequencing, and contained the ampliﬁed Mef2 part oriented in the
sense direction, followed by the intron, and its own antisense-oriented
copy.
Fragments of Act79B and Act88F upstream sequences were ampli-
ﬁed by PCR and cloned into the pCaSpeR-hs-AUG-ßGal (CHAB) vector
(Thummel and Pirrotta, 1992). For generation of Gal4 drivers, the
enhancer sequences recapitulating the entire expression patterns
of Act88F and Act79B genes were ﬁrst ampliﬁed via PCR. The primers
used in these reactions were forward 5′-GAAGAGCATTGGCACCAA
and reverse 5′-TGACAATAGGCTCTCCGTTT to amplify the Act79B
enhancer; and forward 5′-TTGCACTGATAAATGGTCGG and reverse
5′-CGGACCTTAGAAGGACCGA to amplify the Act88F enhancer. Both
amplicons were then cloned into the vector pChsGal4 (Apitz, 2002).
The orientation and integrity of the inserts were veriﬁed by direct se-
quencing of the ﬁnal clones.
Cell culture co-transfection assay
In order to test the silencing potency of the IR2 construct, S2 cells
were co-transfected with: pPacPl–Gal4, to activate expression from
the IR2 construct; pUAST-C–Mef2–IR(2), the Mef2 silencing construct;
pPacPl–Mef2(wt) (Tanaka et al., 2008), to express MEF2; and the
reporter pC9-CHAB, bearing the MEF2-responsive enhancer of Act57B
fused to LacZ (Kelly et al., 2002). The base-line expression control
+ +
+
Mef2 CDS
Isoform complexity
Mef2 IR2
Mef2 IR5039
4
3
2
1re
po
rte
r a
ct
iva
tio
n 
fo
ld
Mef2 (IR2)
Mef2 (wt)
TL TL
TL
TL
TLTL
TL
TL
CONTROL 1151>Mef2 IR
ABDOMEN (filleted) 
TL
H H
TL
TLTL
TL
TL
AL
AD
AD
TLTL
A B
E
100 μmF-actin
THORAX (horizontal) 
T
F
F
E E
F
D
V
V
CONTROL 1151>Mef2 IR
100 μm 
C
F-actin F-actin
THORAX (transverse)
T
L
D
D
CONTROL 1151>Mef2 IR
100 μm 
D
Fig. 1. Structural and functional properties of the inverted repeat (IR) RNAi constructs. A: Mapping the sequences used in two different IR constructs to the coding DNA sequence
(CDS) of Mef2. Isoform complexity depicts the usage of nucleotide sequence in Mef2 annotated transcripts, with the highest plotted value corresponding to usage in all transcripts.
B:Mef2 silencing ability of the Mef2 IR2 construct assayed in cell culture co-transfection assays. Reporter activation was determined as fold ß-galactosidase accumulation, over the
basal ß-galactosidase expression level when the activating Mef2-expressing plasmid was omitted. Expression of ß-galactosidase from the reporter construct was controlled by a
MEF2-responsive enhancer/promoter of the Act57B gene. C, D, E: Comparative analysis of gross muscle morphology between control (on the left of each panel) and RNAi (on
the right of each panel) pharate unhatched adults at 90 h APF on indicated planes of thorax sections (C, D) and abdominal ﬁllets (E), stained for F-actin. The RNAi was activated
by the 1151-Gal4 driver in adult myoblast precursors. The UAS–Mef2 IR constructs were: IR2 (C) and IR5039 (D, E). Arrowheads point to escaper muscles that did form; white
box indicates unusual mini-muscles. E— extracoxal depressor of the trochanter, F— direct ﬂight muscles, T— TDT, D— DLM, V— DVM, L— leg muscles, TL— dorsal internal oblique
muscles, which are temporary muscles of larval origin, AD — abdominal dorsal muscles, AL — abdominal lateral muscles, H — cardiac muscles of the dorsal vessel.
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expression control excluded pUAST-C–Mef2–IR(2). Excluded plasmids
in control transfections were replaced by the empty cell culture
expression vector pPacPl, to maintain total transfecting pDNA at
the same amount. The efﬁcacy of Mef2 silencing was evaluated by
measuring ß-galactosidase activity in experimental and control wells.
Details on cell culture conditions, transfection, and ß-galactosidase
assays were published previously (Tanaka et al., 2008).
Fly stocks and crosses
All experimental crosses were carried out at 25 °C unless otherwise
indicated. Transgenic lines for this study were obtained by P-element-
mediated transformation (Rubin and Spradling, 1982). Several inde-
pendent transgenic lines were created and tested for speciﬁc trans-
gene expression. Transformation with pUAST-C–Mef–IR(2) resulted
in transgenic lines, identiﬁed as 40-1 and 15-2, in which the IR2
transgene locations were mapped to the III and X chromosomes,
respectively. Both of the IR lines demonstrated similar effects in Mef2
RNAi-mediated knock-down, based on immunological staining for
MEF2. In addition, an independent line expressing an alternative
Gal4-inducible Mef2 IR construct 5039 (Fig. 1A) was obtained from
the Vienna Drosophila RNAi Center (VDRC, Vienna, Austria, http://
stockcenter.vdrc.at). This line, designated as 15550, has the Mef2 IR
5039 transgene mapped to the III chromosome. The lines 40-1
and 15550 were additionally combined with the UAS–Dcr2 (II) line
(generously provided by Dr. Sarah Certel, University of Montana, MT,
USA) for enhancement of the RNAi knockdown (Dietzl et al., 2007).
Lines Act79B–Gal4 (79B6) and Act88F–Gal4 (88F2) were obtained
from recombinant pChsGal4 plasmids, and the transgenes for each
driver have been mapped to the X chromosome. These lines were
selected based on the results of a test cross withUAS–LacZ (II) (obtained
from the Bloomington Drosophila Stock Center, Bloomington, IN, USA),
to conﬁrm the speciﬁc and robust ß-galactosidase expression in the TDT
and IFM for lines that were designated 79B6 and 88F2, respectively.
The ﬂy line 1151-Gal4(X)was a gift from Dr. Joyce Fernandes (Miami
University of Ohio, OH, USA), and was described earlier (Anant et al.,
1998; Roy and VijayRaghavan, 1997). A modiﬁcation of this line, 1151-
Gal4; UAS–mCD8::GFP UAS–H2B::YFP; UAS–mCD8::GFP, that was used for
ﬂuorescent tracing of myoblast membranes, was kindly provided
by Dr. Alexis Lalouette, Institut Jacques Monod, CNRS-Université
Paris Diderot, Paris, France. The Act88F IR strain was obtained from
the VDRC (ID#9780). All other ﬂy stocks were obtained from the
Bloomington Drosophila Stock Center (Bloomington, IN, USA).
Identiﬁcation of putative RNAi off-targets
TheMef2 sequence used to generate the IR2 construct was submit-
ted to the on-line tool at the website of the Drosophila RNAi screening
center (http://www.ﬂyrnai.org/RNAi_ﬁnd_frag_free.html), which cal-
culated four putative off-target genes. They are: CG15207, CG9815,
CG15186 (for all, molecular function and mutant phenotype are not
known), and cwo that is a transcriptional repressor, involved in circadi-
an rhythm regulation. Following the same analysis, the alternativeMef2
IR5039 that was obtained from the VDRCwas found to potentially have
one off-target gene: Rab–RP4, a GTPase, experimentally shown to be in-
volved in regulation of cell shape. Since the two IR constructs did not
have overlapping off-targets, we therefore decided to use them both
in experimental crosses, but to consider only common phenotypes in
RNAi-induced mutants.
Histology and staining procedures
For parafﬁn sections, animals removed from the pupal case at indi-
cated stages of development were ﬁxed with 4% paraformaldehyde in
phosphate buffered saline (PBS), at 4 °C overnight. Sectioning andstaining was performed essentially as described earlier (Cripps et al.,
1998; Jaramillo et al., 2009). At each indicated time-point, at least four
specimens (control or RNAi-induced) were analyzed.
Fileting of abdomens of newly eclosed adults was performed as
described (Molina and Cripps, 2001). Formaldehyde-ﬁxed abdomen
preparations were stained with Alexa488-labeled phalloidin (Molecular
Probes) overnight at ambient temperature. Additionally, some abdo-
menswere counterstainedwith anti-MEF2 antibody, as described below.
For cryosections, adults or pupae that had been removed from pupal
cases at indicated developmental times, were mounted in Tissue-Tek
freezing media (VWR Scientiﬁc Products) and snap-frozen in liquid
nitrogen. Sections were cut at approximately 10 μm thickness, using a
Minotome Plus cryotome (Triangle Biomedical Sciences, NC, USA). Sec-
tions, mounted onto histological slides (VWR Scientiﬁc Products), were
ﬁxed for 10 min in PBS containing 0.1% (v/v) Triton X-100 (PBSTx), con-
taining 3.7% formaldehyde, and additionally permeabilized in PBS
containing 0.5% (v/v) Triton X-100 for 30 min. Slides with sections
were stained overnight at 4 °C with rabbit anti-MEF2 serum (a kind
gift of Dr Bruce Paterson, NIH), diluted in PBSTx containing 1% (w/v)
BSA as a blocking reagent. Antigen-bound primary antibody was
visualized with Alexa568-labeled, afﬁnity-puriﬁed, goat anti-rabbit Fab
immunoglobulin fragments (Molecular Probes). Sections were also
counterstained with Alexa488-labeled phalloidin (Molecular Probes),
to visualize F-actin, and with the nuclear stain DAPI (Sigma). Analysis
of ﬂuorescently labeled sections was performed on a laser confocal
microscope, Zeiss 510META in the University of New Mexico & Can-
cer Center Fluorescence Microscopy Shared Resource. During image
acquisition the ﬂuorescent signals were assigned pseudocolors, for
better visualization of experimental phenotypes. Microscopic analy-
sis was carried out for at least ten specimens per genotype, per indi-
cated time-point.
Expression of ß-galactosidase was detected in situ by histochem-
istry. For that, cryosections of thoraces were brieﬂy ﬁxed with 3.7%
(v/v) formaldehyde prepared in PBS, washed thoroughly with sever-
al changes of PBS, and incubated in a standard X-gal staining solution
for 20–30 min at ambient temperature. The reaction was terminated
by washing slides with sections in PBS.
Expression analyses
Samples for quantitative expression analysis were collected directly
from freshly prepared frozen sections of thoraces. For that, 16-μm sec-
tions were brieﬂy dried at ambient temperature and scrapes from
DLMs and DVMs were collected with a fresh 22 G syringe needle, and
deposited directly into the RLT buffer provided by the RNeasy mini-
spin kit (Qiagen). The process of scraping was tightly controlled under
a dissection microscope; a special precaution was made not to collect
material from the TDT and other non-IFM tissues. Each comparative
pair of similarly staged samples contained material collected from one
control (Act88F–Gal4 x w1118) and one RNAi-induced pupa (Act88F–
Gal4 xUAS–Dcr2; UAS–Mef2 IR5039). Total RNA from each sample was
extracted using the RNeasy mini-spin kit (Qiagen), following the man-
ufacturer's protocol. Subsequently, cDNA synthesis was performed
from 55 to 80 ng/sample of freshly isolated RNAwith the use of random
hexamer primers (Roche) and the SuperScript II kit (Invitrogen). Dilut-
ed cDNA was used as template for real time qPCR ampliﬁcation. The
primers used to detect experimental Act88F and Mhc, as well as refer-
ence 18S and 28S targets are listed in Table 1. The ampliﬁcation efﬁcien-
cies for these primers were 80–85%, as determined experimentally.
Ampliﬁcation reactions were set up in triplicates using SYBR Green
PCRMaster kit (Applied Biosystems) and run in an ABI Prism 7000 ma-
chine (Applied Biosystems); background and threshold cycles (Ct)were
determined in the automated mode by the ABI Prism 7000 SDS Soft-
ware (Applied Biosystems). For each sample, qPCR data were calculated
from an average difference between Ct of gene of interest and Ct of the
two reference ribosomal RNA genes, 18S and 28S (Schmittgen and
Table 2
The viability of Mef2 RNAi and control genotypes.
Cross (♀ x ♂) ♂♂
# eclosed
♀♀
# eclosed
♀♀
eclosed,%
[control] w1118 x 1151-GAL4 (X) 112 124 53%
UAS–Mef2 IR2 (X) x 1151-GAL4 (X) 204 0 0%
UAS–Mef2 IR5039 (III) x 1151-GAL4 (X) 170 0 0%
Table 1
Primer sequences used in this study for analytical PCR analysis.
Target Forward primer Reverse primer
Act88F 5′-CTTCATGGCCATTTCATCG 5′-TACTCGACATGGAGCACAGC
Mhc 5′-TTGATGACCACTCTGCGTTC 5′-TTCAAGCACACCGTTACAGG
28S 5′-CAGGTTGAAGTCAGGGGAAA 5′-ATGGTTCGATTGGTCTTTCG
18S 5′-TTCATGCTTGGGATTGTGAA 5′-GGGACGTAATCAATGCGAGT
sing 5′-TTCGGCAGTCACTATTCGAG 5′-GAACTGCGGATGTAGCCATAC
lmd 5′-CAGACAACTGCCGGAAATG 5′-TCTCTGGTGATTTGCTGTCG
RpL30 5′-TGAAGTCCAGCACTACAGCG 5′-ATGATGTCCGAATCTCCAGG
blow 5′-GAGGCAAGCATCTCCAGATAAC 5′-TGGTCGACTGTGTCGATAGC
mbc 5′-CATCGACATGATTGGCTGTC 5′-CGCACATGTTCAAAGACCTG
Act5C 5′-AAGGATCGCTTGTCTGGG 5′-GTATATCATATCATATCTCATGTGG
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repeats of similarly staged control and RNAi samples were subjected
to a paired, two-tail Student's t-test. Expression between control and
RNAi samples was considered statistically non-signiﬁcant for p-value
>0.05.
In the analysis of transcripts recovered from fusing myoblasts, real
time PCR was not practical due to the low RNA yield in dissected sam-
ples, and the subsequent low abundance of the target templates.
However, signiﬁcant differences in the expression levels for some
genes between control and RNAi samples allowed them to be visual-
ized by the means of end-point PCR. For that, samples of the DLM
fusion templates and surrounding myoblasts were collected from
serial frozen sections of four control (w1118) and Mef2-silenced (UAS–
Dcr2; UAS–Mef2 IR5039 x 1151-Gal4; Twi–LacZ) pupae, staged at 25 °C
for 24 h APF. Samples were scraped from the appropriate region of a
cryosection using a pulled glass capillary needle and a hydraulicmanip-
ulator, visualized under an invertedmicroscope. RNAwas puriﬁed from
these samples as described above. The primers used to amplify selected
targets from the extracted DLM template/myoblast RNA are summa-
rized in Table 1. All PCRs were run simultaneously, under identical
conditions. The resulting products were loaded equally and resolved
in a 2% agarose gel for image analysis.
Results
Generation and veriﬁcation of a Mef2 RNAi line
To circumvent the absolute requirement of MEF2 for embryonic
myogenesis, we applied an inducible tissue-speciﬁc RNAi technique
to knock downMef2 expression at later developmental stages. We cre-
ated an inverted repeat construct, termed IR2, that produced double-
stranded RNA corresponding to an approximately 700-bp region of
the Mef2 coding sequence, to initiate RNAi against native Mef2 tran-
scripts (Fig. 1A). This construct was ﬁrst tested in Drosophila cultured
S2 cells: when co-transfected with a Mef2 expression plasmid and a
MEF2-dependent reporter, the dsRNA expression from IR2 completely
abrogated reporter gene activation, which demonstrated strong silenc-
ing potency provided by IR2 to its target (Fig. 1B). This ﬁnding enabled
us to use an RNAi approach to attenuate Mef2 expression, using this
construct in transgenic animals. For comparison and conﬁrmation, we
also obtained a Mef2 RNAi transgenic line from the Vienna Drosophila
RNAi Center (Dietzl et al., 2007). The Mef2 IR construct 5039 (IR5039),
expressed by this line, was designed to target a different portion of
theMef2 coding region (Fig. 1A, and the VDRC web resource).
Silencing of Mef2 in adult myoblast progenitors results in the loss of adult
somatic muscles
Experimental induction of Mef2 RNAi was carried out in transgenic
ﬂies with the use of the Gal4/UAS binary inducible expression system
(Brand and Perrimon, 1993). First, we evaluated the progeny of the
cross between Mef2 IR2-carrying ﬂies (UAS–Mef2 IR2) and the adultmyoblast-speciﬁc driver line 1151-Gal4 (Anant et al., 1998). Since
both of the transgenes in the parental lines were located on the X chro-
mosome, only female progeny were expected to have RNAi activation
and Mef2 silencing in developing adult myoblasts. Therefore, male off-
spring served in this cross as the control. Consistently, no adult female
progeny were recovered from this cross (UAS–Mef2 IR2 x 1151-Gal4,
Table 2). In contrast, the abundance of female progeny from a control
crosswas normal (w1118 x 1151-Gal4, Table 2). Preliminary examination
showed that 1151>Mef2 IR2 females developed normally, but remained
in their pupal cases and eventually died, unable to eclose. Subsequent
histological analyses revealed that these animals lacked essentially all
major somaticmuscles in their bodies, including IFMs, TDTs, legmuscles
and abdominal bodywallmuscles (Fig. 1C–E). The onlymuscles remain-
ing in the thorax of the RNAi ﬂies were a few escaper muscles (Fig. 1C)
and some miniature muscles (Fig. 1D, boxed region). The thorax cavity
in 1151>Mef2 IR2 pharate adults contained no obvious structures or tis-
sues in place of themuscles. In the abdomen of these ﬂies, virtually all of
the transverse and longitudinal muscles were absent (Fig. 1E). There
were also a few escaper muscles observed. In addition, other muscle
types, including the temporary oblique dorsal muscles of larval origin,
were unaffected. These muscles were positive for MEF2 expression
(not shown). Cardiac and visceral musculature in the RNAi animals
remained intact and continued expressing Mef2 (Fig. 1E and data not
shown), presumably due to the inactivity of the 1151-Gal4 driver in
these muscles.
To exclude the possibility that the observed phenotype might arise
from silencing of possible “off-target” genes by the RNAi (Ma et al.,
2006, see Materials and methods), we also tested another RNAi trans-
gene,Mef2 IR5039 (Dietzl et al., 2007). When UAS–Mef2 IR5039 females
were crossed with males of the 1151-Gal4 line, their female progeny
essentially recapitulated all of the described phenotypes observed
for crosses with UAS–Mef2 IR2 ﬂies (Table 2 and data not shown).
Thus, these studies have validated twoMef2 RNAi constructs as having
similar effects. More importantly, our data expand upon our earlier
studies (Baker et al., 2005) by showing a more important requirement
for MEF2 function in the formation of the adult skeletal muscles in
Drosophila.
Silencing of Mef2 at early stages of adult myogenesis impairs myoblast
fusion and muscle structural protein gene expression
To investigate what problems in muscle development arise upon
Mef2 silencing in adult myoblasts, samples from a series of develop-
mental time-points were subjected to comparative analysis between
control and RNAi pupae, in which Mef2 silencing was induced by
the 1151-Gal4 driver. This driver is active in adult myoblasts at the
larval stage and extending into the pupal stage (Anant et al., 1998;
Roy and VijayRaghavan, 1997), thus bracketing the earliest expression
of Mef2 in all developing adult muscles. During this study we focused
on the developing IFMs: these muscles are the largest in the ﬂy body,
and therefore easily identiﬁed at all stages of development. Parafﬁn sec-
tions of thoraces were obtained for times corresponding to the active
phase (24 h after puparium formation (APF)) and the ﬁnishing phase
(30 h APF) of hyperplastic muscle growth (i.e. by myoblast fusion), as
well as the phase of hypertrophic (i.e. by size increase) muscle growth
(48 h APF). All sections were stained with hematoxylin and eosin
(H&E) to reveal general tissue morphology.
196 A.L. Bryantsev et al. / Developmental Biology 361 (2012) 191–207In developing pupae, adult muscles begin to form via myoblast
fusion. Among the IFMs, the dorsal longitudinal muscles (DLMs) have
pre-established fusion templates, that are formed on the basis of the lar-
val oblique muscles (LOMs). By contrast, the dorso-ventral muscles
(DVMs) are formed de novo, fusion being initiated by individual founder
cells (Atreya and Fernandes, 2008; Fernandes et al., 1991). In each
hemisegment, the original three LOMs undergo splitting to give rise to
six DLM templates. On transverse sections of 24 h APF control pupae,
all six developingDLM ﬁbers could be identiﬁed, surrounded by numer-
ous swarming myoblasts participating in fusion (Fig. 2A, left panel). In
similarly staged Mef2-knockdown pupae, template splitting did not
proceed, and the number of DLM templates remained at three. These
templates were smaller than their control counterparts, whereas the
layer of swarming myoblasts surrounding them was signiﬁcantly
thicker than in control (Fig. 2A, right panel). For the DVMs, each wild-
type DVM ﬁber was detected at 24 h APF as a central core element,CONTROL 1151>Mef2 IR
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induced with the 1151-Gal4 driver activating UAS–Mef2 IR5039. DT — DLM template, M —being the product of myoblast fusion to founder cells, and surrounded
by swarming myoblasts (Fig. 2B, left panel). Identiﬁcation of nascent
DVMs in Mef2-knockdown pupae was problematic due to the lack of
myoblast fusion products. Groups of myoblasts could be found at the
putative sites of DVM formation, but they never were accompanied by
a fusion core (Fig. 2B, right panel).
At 30 h APF, the fusion of IFMs is largely complete in wild-type
Drosophila, and these muscles become morphologically distinct. At
this time-point, freshly formed myoﬁbers were apparent in control
animals as intensely stained structures, associating with sparse myo-
blasts (Fig. 2C, left panel). Fused myoﬁbers were not found in Mef2-
knockdown pupae, but instead the presence of large numbers of
unfused myoblasts was apparent (Fig. 2C, right panel). These myo-
blasts concentrated into irregularly shaped swarms at the dorsal
side of the thorax, and on transverse sections the myoblast swarms
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often found localizing sideways to the myoblast swarms, and were
surrounded by somewhat less myoblasts than seen around them at
24 h APF (Fig. 2C, right panel).
At 48 h APF, control IFMmyoﬁbers demonstrated adult-like appear-
ance in their shape, ﬁber number, and position (Fig. 2D, left panel). In
contrast, RNAi pupae at 48 h APF continued to show a lack of fused
myotubes. Moreover, the number of myoblasts in these pupae de-
creased signiﬁcantly, and they could be detected only as small groups
of loosely aggregated cells (Fig. 2D, right panel). We hypothesize that
by this stage most of the unfused myoblasts have undergone cell
death, and that the residual thoracic mini-muscles that we see in
adult RNAimutants (Fig. 1D, frame) arise from themyoblasts remaining
at 48 h APF.
We additionally traced myoblasts with a membrane-associated GFP
marker, mCD8-GFP, that was expressed under the control of the 1151-
Gal4 driver. At 24 h APF, wild-type myoblasts concentrating around
the DLM templates appeared as a compact mass of cells with their
membranes in close contact with each other (Fig. 3A, left panel). Induc-
tion of Mef2 RNAi by the 1151-Gal4 driver resulted in a signiﬁcant de-
crease of the MEF2 protein level in DLM fusion templates and free
swarming myoblasts, as determined by immunoﬂuorescence at 24 h
APF (Fig. 3B).Mef2-knockdown myoblasts were not closely compacted
around their fusion templates. Rather, these myoblasts localized loose-
ly, with noticeable space between individual cells (Fig. 3A, right panel).
Both H&E and ﬂuorescent preparations strongly suggested that Mef2-
silencedmyoblasts could not complete cell fusion to formmultinucleate
myotubes. To test whether the knock-down ofMef2 impairs expression
of genes essential for myoblast fusion, we carried out end-point RT-PCR
analysis on RNA samples obtained from myoblasts at 24 h APF (the
method used to collect pure muscle/myoblast samples is detailed in
Materials and methods). Our molecular data indicated that expression
of at least one fusion-critical gene, singles bar (sing), was clearly
down-regulated in Mef2-knockdown myoblasts (Fig. 3C). The sing
gene encodes a membrane protein that is critical for myoblast fusion
during embryonic myogenesis, being expressed in both fusion-
competentmyoblasts and founder cells (Estrada et al., 2007). Therefore,
the loss of sing expression in adult myoblasts can certainly account for
the fusion failure that we have documented. In contrast to sing, expres-
sion of other well-known fusion genes, blow andmbc, were unaltered
in Mef2-knockdown myoblasts (Fig. 3C). Our data provide a mecha-
nistic explanation for the failure of fusion in the Mef2-knockdown
myoblasts, although it is interesting to note that MEF2 does not con-
trol expression of the whole repertoire of fusion genes.
We also investigated how the initiation of muscle structural gene
expressionwas affected inMef2-knockdownmyoblasts and fusion tem-
plates at 24 h APF, using identical sampling technique, as described
above.We chose Act88F andMhc as representatives of two distinct clas-
ses of adultmuscle genes, whose expression is either restricted to only a
subset of adult muscles (Act88F) or present in all adult muscles (Mhc).
In our analysis, the control sample demonstrated robust presence of
Act88F and Mhc transcripts, while the RNAi sample failed to demon-
strate any signiﬁcant expression of both of the genes (Fig. 3D).We con-
clude that in nascent IFMs, as exempliﬁed by DLM templates at 24 h
APF, Mef2 knockdown with the 1151-Gal4 driver largely abolished the
initiation of expression for both Act88F andMhc.
These ﬁndings expand upon our earlier studies (Baker et al., 2005), by
demonstrating a more crucial role for MEF2 function in the formation of
the adult muscles, where Mef2-knockdown myoblasts fail to fuse to
form myotubes and mature muscles, and this occurs at least in part
through a requirement of MEF2 for the expression of the fusion gene,
sing. Interestingly, myoblast migration was not suppressed by Mef2
knockdown, as judged by the ability of Mef2-knockdown myoblasts to
migrate away from developing imaginal disks and to accumulate in the
thorax near their muscle templates. We further demonstrate that MEF2
function in adults is critical for the initiation of structural gene expression.Generation of Gal4 drivers active in post-fusion adult muscles
Immunoﬂuorescent analysis of the very few mini-muscles that
formed in the 1151>Mef2 IR pharate adults (Fig. 1D, right panel)
revealed that the myoﬁbers contained severely reduced amounts of
MEF2 (not shown). However, these mini-muscles could complete
their differentiation, as conﬁrmed by the presence of detectable F-
actin. Hence, it was possible that MEF2 could be less strictly required
for steps in muscle development following myoblast fusion.
To test this possibility, Mef2 had to be silenced later in adult myo-
genesis, so that its requirement for myoblast fusion could be circum-
vented. Thus, a Gal4 driver should initiate expression of Mef2 IR
constructs in myotubes immediately after fusion. Assuming that en-
hancers for adult muscle-speciﬁc structural geneswould be good candi-
dates for this task, we generated two such drivers, by identifying and
cloning the enhancer regions for the IFM-speciﬁc Act88F gene, and for
the TDT-speciﬁc Act79B gene (Fig. 4A, C). For Act88F, a potent enhancer
for expression in IFMs, ~300-bp in length, lies approximately 1 kb up-
streamof the transcription start site; and for Act79B, a ~400-bp genomic
region with TDT-speciﬁc enhancer activity, lies in a similar position rel-
ative to the transcription start site of its gene.When fused toGal4, prop-
er stage- and tissue-speciﬁc activities of the cloned enhancers were
conﬁrmed by crossing transformant lines with UAS–LacZ ﬂies, and
detecting ß-galactosidase activity in sections. As expected, the Act88F
driver was active speciﬁcally in IFMs and not the TDTs (Fig. 4B), while
the Act79B driver was active in a complementary pattern, in TDTs but
not IFMs (Fig. 4D). Importantly, neither driver was active in unfused
myoblasts (data not shown). In a separate experiment, we subjected
Gal4-expressing ﬂies to microscopic analysis and veriﬁed that expres-
sion of these Gal4 transgenes alone did not cause muscle structural de-
fects (not shown).
Silencing of Mef2 in indirect ﬂight muscles perturbs myoﬁbril organiza-
tion, but does not affect maintenance of two major structural genes
We ﬁrst analyzed the effects of Mef2 silencing in the post-fusion
IFMs, using the Act88F–Gal4 driver. In this cross, IFMmyoﬁbrillogenesis
following post-fusion Mef2-knockdown did not stall, and myoﬁbrils
were observed developing at 48 h APF (Fig. 5A). By the end of the
pupal stage,Mef2 knockdown induced by the Act88F driver had a specif-
ic impact on the integrity of a subset of IFMs: in most cases, Mef2-
knockdown DLMs often collapsed to the back of the thorax (Fig. 5B).
Nevertheless, RNAi DVMs developed normal-looking myoﬁbrils by the
end of the pupal stage, although they were somewhat wavy in their
organization (Fig. 5C).
To assess howMef2 knockdown can inﬂuence expression ofmyoﬁber-
speciﬁc and pan-muscular-speciﬁc structural genes, we examined by
quantitativeRT-PCR the levels of expressionofAct88F andMhc at different
developmental time-points inwild-type andAct88F-directedMef2 knock-
down pupae. We found that, at most time-points tested, the levels of
Act88F and Mhc transcripts did not show any statistically signiﬁcant
changes in knockdown versus controlmuscleﬁbers (Fig. 5D). The only ex-
ception to this result was for Act88F transcripts at 48 h APF, where tran-
scripts in knockdown muscles were signiﬁcantly reduced compared to
controls. This effect upon Act88F transcripts was not observed at later
pupal time-points.
To determine if the observed minimal effect upon structural gene
expression and myoﬁbril assembly in the Act88F>Mef2 IR cross was
due to residual MEF2 activity in the knockdown muscles, we carried
out two additional experiments: we performed the RNAi experiment
in a Mef2P544/+ genetic background, generating haploinsufﬁciency
for the endogenousMef2 gene on top of the knockdown; and we com-
bined the two RNAi lines to maximize the effects of the RNAi. In addi-
tion, to maximize the transcriptional activity of the GAL4 driver, and
thereby to further increase the effectiveness of RNAi knockdown,
pupae were incubated at 29 °C. Interestingly, there was worsening
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Fig. 3.Mef2 knockdown in adult myoblasts compromises myoblast behavior at fusion centers and prevents expression of fusion and muscle structural genes. A: Transverse sections
across developing DLM ﬁbers at 24 h APF are shown for control and RNAi (1151>Mef2 IR5039) conditions. The signal is recorded from membrane-associated mCD8:GFP protein
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iments with DVM myoﬁbrils appearing more disoriented, slightly
thinner and with less distinct Z-lines and M-lines (Fig. 6A). Neverthe-
less, we also saw no reduction in Act88F nor Mhc transcription levels
at the end of pupal development in any of the enhanced crosses
(Fig. 6B).
From these observations, we make two important conclusions:
ﬁrstly, since haploinsufﬁciency forMef2 enhanced the mutant pheno-
type, this suggests that there is yet some residual MEF2 activity in the
knockdown muscles. On the other hand, since the levels of two key
myoﬁbrillar protein genes were not attenuated in the haploinsufﬁcientbackground nor in the double-RNAi background, we conclude that
much of adult myoﬁbrillogenesis proceeds independently of MEF2.
This will be discussed at greater length in the Discussion.
Silencing of Mef2 in post-fusion TDT myotubes does not prevent ﬁbri-
llogenesis, but results in myoﬁbrillar disorganization
We next analyzed the effects of Mef2 reduction in the post-fusion
TDT. To understand the kinetics of Mef2 silencing in this muscle, we
analyzed a time series of samples collected at 30 h APF (the active
phase of TDT myoblast fusion in wild-type), 48 h APF (when TDT
Fig. 4. Characterization of the enhancer regions used in post-fusion-activated Gal4 drivers. A, C: The structure of Act88F (A) and Act79B (C) genes. Red and orange rectangles indicate
non-coding and coding exons, respectively; white boxes represent introns. The cloned fragments used for enhancer activity analysis, their precise boundaries related to the tran-
scriptional initiation site, and in vivo activities are indicated below each gene scheme. All drawings are to scale and oriented to the respective gene schemes. The selected enhancers,
used in Gal4 drivers, are framed. B, D: Expression of Act88F–Gal4 (B) and Act79B-Gal4 (D) drivers, as revealed by activation of a UAS–LacZ construct. ß-galactosidase enzymatic
activity was detected in situ on horizontal thorax sections using X-gal. T — TDT, D — DLM, V — DVM.
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hyperplastic muscular growth), and past 90 h APF (the end of pupal
myogenesis). The pupae in which Mef2 RNAi was activated by the
Act79B–Gal4 driver were compared with similarly staged control ani-
mals in which the driver was not present. All samples were collected
as cryosections transverse to the TDT; these sections were then ana-
lyzed by confocal microscopy. Moreover, both RNAi lines were used
for this analysis, and we observed identical phenotypes in each experi-
mental case.
In the TDT,myoﬁbers formvia fusion that occurs at the outer periph-
ery of the myoblast swarm (Jaramillo et al., 2009; Rivlin et al., 2000).
Therefore, at 30 h APF, the newly forming TDTs had a core that con-
tained tightly packed individual myoblasts expressing Mef2, while the
peripheral ring was a product of myoblast fusion, in which expression
of structural genes was activated (Fig. 7A, left panel, inset). Induction
of Mef2 RNAi via the Act79B–gal4 driver resulted at 30 h APF in clearly
diminished immunoﬂuorescence of MEF2 in the fused myotubes at
the periphery, but not in the centrally-located myoblasts (Fig. 7A, right
panel, arrowheads).
At 48 h APF, when the fusion process was complete, control TDT
muscles adopted their typical oval cross-sectional shape, comprising
24–28 individual myoﬁbers linked together (Fig. 7B; O'Donnell et
al., 1989; Peckham et al., 1990). By this time-point, MEF2 immunoﬂu-
orescence in RNAi TDTs was very close to the background level,
whereas MEF2 immunoﬂuorescence in the adjacent IFMs was normal.
At 72 h and 90 h APF, control TDT myoﬁbers demonstrated expand-
ed amounts of F-actin that ﬁlled outmost of themyoﬁber volume, tight-
ly surrounding the nuclei (Fig. 7C–D, left panels). At these time-points
MEF2 protein could not be immunologically detected in Mef2-silenced
TDTs. Nevertheless, such RNAi-induced TDT myoﬁbers contained
densely packedmyoﬁbrils (Fig. 7C–D, right panels), indicating that accu-
mulation of muscle structural genes was not stalled in the absence of
MEF2. The other persistent features of Mef2-knockdown TDTs were:
the presence of a central cavity within the center of TDT myoﬁber
rosette, that is usually minimized in mature wild-type TDT; wider
gaps between individual TDT myoﬁbers; mis-localized and aggregatednuclei; and reduced overall size of the muscle (Fig. 7C–D, right panels).
By counting the numbers of TDT ﬁbers in RNAi samples at 48, 72, and
96 h APF time points, the reduction in TDT size was not due to a loss
of ﬁbers, and therefore arose from reduced size of the individual ﬁbers.
We also studied ﬁbrillar organization within individual myoﬁ-
bers, in control and Mef2-knockdown TDT muscles. Each mature
TDT ﬁber contains a double-ring of tightly-packed parallel myoﬁbrils
surrounding centrally-located nuclei (see Fig. 7D, left panel). At
higher magniﬁcation of pupal samples, it was apparent that the
outer ring of myoﬁbrils was laid down ﬁrst during development
(Fig. 8A, left panel), and by the pharate adult stage individual myoﬁ-
brils could be discerned in cross section as small oblongs, numbering
150–200 per TDT large muscle ﬁber (Fig. 8B, left panel; O'Donnell et
al., 1989; Peckham et al., 1990). In Mef2-knockdown TDT at 48 h
APF, there was also evidence of F-actin accumulation, although the
intensity of staining was highly irregular across individual myoﬁbers
(Fig. 8A, right panel). By 90 h APF, the F-actin accumulation in RNAi
TDT myoﬁbers was even more signiﬁcant (Fig. 8B, right panel). How-
ever, at both time-points in RNAi TDT samples, it was difﬁcult to dis-
cern individual myoﬁbrils in cross-section, arguing that the myoﬁbrils
were not arranged parallel to the axis of the muscle, but were irregular
in their organization.
In summary, depletion of MEF2 from TDT muscles shortly after
fusion did not prevent muscle structural gene expression. Neverthe-
less, similar to the case for the IFMs, MEF2 function was required in
developing TDTs for proper arrangement of the muscle ﬁbers, and
correct arrangement of myoﬁbrils within muscle ﬁbers.
Altogether, our combined morphological and molecular data indi-
cate that knockdown of Mef2 in post-fused adult muscles does not
abolish myoﬁbrillogenesis, which is in contrast to the extensive re-
quirement for MEF2 in myoblast fusion and in the initiation of muscle
structural gene expression during early (24 h APF) myogenesis. How-
ever, the myoﬁbril disorganization and DLM collapse that are associ-
ated with post-fusion Mef2 knockdown in IFMs and TDTs, indicate
that some aspects of muscle development remain sensitive to the
presence of MEF2.
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(red), and myoﬁbrils (gray) in control and RNAi pharate adults (Act88F>Mef2 IR5039) at 90 h APF. Lack of MEF2 results in a wavy arrangement of myoﬁbrils, although their struc-
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scripts of interest, and 18S and 28S rRNA, used as internal references (details are in Material and methods) ±s.d. Student's t-test p value >0.05 indicates statistically non-signiﬁcant
differences. Note that the expression of Act88F lags slightly in the RNAi samples at the 48 h APF time-point, but not at any other stages. Mhc transcript levels are not signiﬁcantly
different between control and knockdown samples.
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orative effect
Protein synthesis signiﬁcantly slows down in adult ﬂies (Clarke and
Smith, 1966; Smith et al., 1970), although Mef2 expression in muscles
continues throughout their whole life. We therefore sought to deﬁne
a role for MEF2 in adult animals, a question that had yet to be
addressed in detail.
For induction ofMef2 RNAi in fully grown adult muscles, the DJ694–
Gal4 driver was employed, which shows a dramatic induction of Gal4
expression immediately following eclosion. To ensure effective and
quick removal of the MEF2 protein from the muscles of freshly eclosedadults, all staging times were conducted at 29 °C, which enhances the
effectiveness of the Gal4 system (Michelson, 1994). The DJ694–Gal4
driver becomes initiated in adults, especially in IFMs, upon eclosion.
This driver remains active during the whole adult life span (Seroude
et al., 2002). Indeed, the progeny of the cross between DJ694–Gal4
ﬂies and Mef2 IR lines developed normally at 29 °C and showed intact,
Mef2-expressing thoracic muscles within the ﬁrst day after eclosion
(ae) (Fig. 9A). However, within the ﬁrst two days ae, MEF2 protein
levels in IFMs decreased dramatically, and by the third day ae MEF2
could not be detected by means of immunoﬂuorescence in the nuclei
of IFMs, while the TDT had signiﬁcantly reduced levels of MEF2 immu-
noﬂuorescence. In contrast to IFMs and TDTs, MEF2 levels remained
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types of adult muscles (not shown).
Despite the efﬁcient knockdown of Mef2 in IFMs shortly after
eclosion, the RNAi-induced ﬂies did not show any gross aberrations
in their locomotion until day 6 ae. At that time, the ﬂies in which the
RNAi was mediated by the Mef2 IR5039 construct demonstrated a
signiﬁcant decrease in responses to external stimuli and then rapid-
ly died within the following day. In contrast, the ﬂies in which the
DJ694-induced RNAi was mediated by the Mef2 IR2 construct, tar-
geting a different region in Mef2 (Fig. 1A), did not show enhanced
death for more than 3 weeks of monitored observation at 29 °C.
Mef2 silencing directed by the IR2 construct was complete. The
knockdown also effectively targeted the IFMs and, to a lesser degree,
the TDT (Fig. 9B). Since both of the RNAi constructs, IR5039 and IR2,
can potentially mediate RNAi to a few off-target genes, and since
their off-targets are not overlapping (see Materials and methods),
we reason that the effects on the life span rendered by the IR5039
is not speciﬁc to MEF2 depletion, and that the phenotypes arisingfrom expression of the IR2 construct represents the most relevant
effect of Mef2 knockdown.
The loss of MEF2 protein in IFMs of the DJ694>Mef2 IR2 ﬂies was
conﬁrmed at day 3 ae (not shown) and persisted until at least day 14
ae (Fig. 9B). MEF2-depleted IFMs did not bear detectable morpholog-
ical abnormalities in myoﬁbril structure (Fig. 9B, right panels). Con-
comitantly, the ﬂies with silenced Mef2 at this age did not show any
signiﬁcant reduction in their ﬂight ability (not shown).
Since the turnover of structural muscle proteins in adult ﬂies was
reported to stay at very low levels (Clarke and Smith, 1966; Smith et
al., 1970), we decided to test the effect of direct silencing of one of the
major IFM structural components, Act88F. First, the effectiveness of
the Act88F IR construct mediating RNAi was tested in post-fused
IFMs, using the Act88F–Gal4 driver. In RNAi pupae at 72 h APF, IFMs
did not showmature myoﬁbrils. This result conﬁrmed that Act88F de-
pletion was functioning efﬁciently, and justiﬁed the silencing potency
of the Act88F IR construct (Fig. 10A). Next, we conducted Act88F RNAi
in adult ﬂies using the DJ694 driver essentially in the same way as in
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Fig. 7.Mef2 knockdown in developing TDTs results in moderate, but persistent, changes in muscle morphology. A–D: Transverse section through developing TDT ﬁbers at 30 h (A),
48 h (B), 72 h (C), and 90 h [pharate adult] (D) APF in control and (1151>Mef2 IR5039) RNAi pupae. Samples are immunoﬂuorescently stained for MEF2 (green), DNA (red), and F-actin
(gray). TheMef2 silencing was induced with the Act79B–Gal4 driver and was evident by reduced MEF2 immunoﬂuorescence, readily noticeable in the nuclei of fused ﬁbers at 24 h APF
(arrowhead). Insets in panel A show the appearance of developingmuscle ﬁbers at the periphery of the myoblast swarm, that contain increasing amount of polymerized actin; theMEF2
positive nuclei in the center belong to unfusedmyoblasts. Note that, at later stages, MEF2 immunoﬂuorescence is either severely reduced (B) or not detected (C, D) in TDT, but stay at high
levels in unaffected neighboring muscles. Anterior is to the left.
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RNAi up to 31 day at 29 °C, did not show compromised ﬂight ability
nor structural defects to IFM myoﬁbrils (Fig. 10B).
We conclude that, in mature adult muscles, MEF2 is dispensable
for the maintenance of normal muscle ultrastructure. It seems likely
that this result is due to the very low turnover of structural proteins
in adult ﬂies, as demonstrated by our Act88F experiment and in agree-
ment with classical studies. We nevertheless acknowledge that MEF2
may play a role in other muscles not impacted by the DJ694 driver,
and it may play roles in muscles that is not assessed by our existing
methods.
To summarize our ﬁndings, we demonstrate that there is an es-
sential early function for MEF2 in promoting myoblast fusion and
the onset of muscle structural gene expression in the developing
adult muscles. By contrast, depletion of MEF2 from nascent muscle ﬁ-
bers later in development resulted in morphological defects in the
muscles, but did not completely block myogenesis. Depletion of
MEF2 from skeletal muscles after eclosion of the adults did not result
in signiﬁcant nor severe phenotypes. These data were collected usinga series of stage- and tissue-speciﬁc Gal4 drivers, and two different
RNAi lines, targeting different portions of the Mef2 transcript. Similar
phenotypic effects were seen for each of the IR constructs when
expressed during the pupal stage. These ﬁndings, and the similarity
in effects of the two RNAi lines, are documented in Table 3.
Discussion
The phenotypes of Mef2 RNAi versus Mef2 mutants
In this manuscript, we demonstrate an important requirement for
MEF2 in the formation of the adult muscles, where early reduction in
MEF2 levels blocks myoblast fusion, and obliterates formation of the
adult somatic muscles. These ﬁndings are more severe than we had
previously reported for a Mef2 temperature-sensitive combination
(Baker et al., 2005); why should this be the case? The most reasonable
explanation for this discrepancy is that the temperature-sensitive
mutants, while severely impacting MEF2 function, nevertheless still
showed some low level of MEF2 activity and myogenic potential, and
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Fig. 8. Mef2 knockdown in the TDT does not prevent myoﬁbrillogenesis, but affects or-
ganization of myoﬁbril arrays and general myoﬁber morphology. A, B: Transversely cut
individual TDT muscle ﬁbers at 48 h (A) and 90 h (B) APF, in control and RNAi
(1151>Mef2 IR5039) pupae. The superimposed images of three ﬂuorescent channels,
corresponding to MEF2 (green), DNA (red), and F-acting (gray) are shown. The yellow
color indicates an overlap between the green and the red signals. Note that nuclei of
RNAi ﬁbers contain only the red signal and are signiﬁcantly disorganized. Fibrillar orga-
nization is disturbed in RNAi ﬁbers at both time points, but the sizes of individual myo-
ﬁbrils have increased between 48 h and 90 h APF.
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genesis. An additional factor to consider is the period of time that it
takes for the ﬁrst steps of myogenesis to occur, at the adult stage versus
the embryonic stage. In embryos, the fusion process is completed with-
in a time window of just a few hours (Bate, 1990); whereas in adult
myogenesis, fusion proceeds over the course of at least 12 h of pupal de-
velopment (Fernandes et al., 1991). It is feasible then, that low levels of
sustained MEF2 function over an extended period of time are sufﬁcient
to support the earliest steps of adult muscle development, while such
an effect is not possible in embryonicmyogenesis, due to its strictly lim-
ited timing.
We present data indicating that there is yet some residual MEF2
accumulation in the skeletal muscles of some of the RNAi lines thatwe have characterized, since haploinsufﬁciency for Mef2, or use of a
double-RNAi, exacerbated the myoﬁbrillar defects in post-fusion
Mef2 knockdowns. Nevertheless, these levels must be extremely
low, given our immunoﬂuorescent data indicating that indeed levels
of MEF2 are reduced to background detection levels from as early as
24 h APF time-points. More importantly, neither haploinsufﬁciency
for Mef2 nor the double-RNAi background reduced the levels of
Act88F and Mhc expression. We therefore conclude that there are
clear stage-speciﬁc requirements for this important transcription fac-
tor, where higher levels of MEF2 are required for early myogenesis,
but later myogenesis appears to proceed with only minimal levels
(if any) of MEF2 function required.
Regulation of adult myoblast fusion by MEF2
Fusion defects occur in null Mef2 mutants during embryogenesis
(Bour et al., 1995; Lilly et al., 1995), however such a phenotype has
not yet been reported for adult myogenesis. Our study, demonstrating
a requirement for MEF2 in adult myoblast fusion, therefore under-
lines a similarity between these two distinct phases of Drosophila
muscle development. Our data suggest that the abolition of myoblast
fusion is at least partly due to the signiﬁcant down-regulation of sing
transcripts, in samples of puriﬁed myoblasts plus myotubes isolated
from cryosections. sing expression was also decreased inMef2mutant
embryos (Sandmann et al., 2006), conferring another level of similar-
ity between the molecular mechanisms regulating myoblast fusion in
embryonic and adult myogenesis. Importantly, the expression levels
of two other tested fusion genes, blow and mbc, did not show any de-
tectable alterations in expression in response toMef2 knockdown. We
conclude that MEF2 is not a key regulator for multiple fusion genes,
although it certainly is essential for fusion via activation of sing tran-
scription. We note that mbc is not exclusively expressed in develop-
ing muscles, and is in fact more broadly-distributed (Erickson et al.,
1997), reducing the likelihood that its expression solely responds to
MEF2 activity. Whether there are more MEF2-dependent fusion genes,
and whether MEF2 is a direct transcriptional activator of such genes,
is yet to be fully established at either the embryonic or the adult stages.
Initiation of myoﬁbrillar protein gene expression depends upon MEF2
Our ﬁndings also demonstrate that the transcriptional initiation of
genes encoding adult myoﬁbrillar protein genes depends upon MEF2
being present early in muscle formation. Whereas a sample from con-
trol muscle fusion templates plus myoblasts showed robust expres-
sion of both Act88F and Mhc at 30 h APF, Mef2-knockdown samples
showed sparse activation of these muscle structural genes (Fig. 3D).
Our ﬁndings are consistent with the role of Mef2 in embryonic myo-
genesis, where the majority of muscle-speciﬁc genes fail to become
expressed in the absence of MEF2 function (Bour et al., 1995; Lilly
et al., 1995). Clearly, a role for MEF2 in the early stages of muscle for-
mation appears to be a commonality between embryonic and adult
early myogenesis. Nevertheless, some intermediate factors must also
be important in this initiation process, sincewehave yet to demonstrate
that adult actin gene expression is directly responsive toMEF2 (see dis-
cussion below).
A limited role for MEF2 in differentiation of post-fused myoﬁbers
In agreement with our earlier data, there is clearly a more moder-
ate requirement for MEF2 function in formation of the adult muscles
following myoblast fusion. Despite MEF2 being immunologically
undetectable shortly after fusion in RNAi animals, signiﬁcant myo-
genesis occurs, and this process results in the formation of muscles
in pharate adults. This ﬁnding is in contrast to Mef2 knockdown
during the early stages of adult myogenesis, where it was absolutely
required for activation of ﬁbrillogenesis.
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Fig. 9. Mef2 knockdown in post-developed IFMs does not compromise muscle morphology. A, B: Major thoracic muscles of control and RNAi (DJ694>Mef2 IR2) males at 1 day ae
(ae) (A), or 14 days ae (B), stained for MEF2 (green), DNA (red), and F-actin (gray). The ﬂies were raised at 29 °C. Note that MEF2 immunoﬂuorescence in DLMs (D) and DVMs (V) is
reduced at 1 day ae, and not detected at 14 days ae in RNAi ﬂies, while staying unchanged in control and RNAi non-affected direct ﬂight muscles (outlined with dashed line). MEF2
immunoﬂuorescence in the TDT (T) of RNAi ﬂies is also reduced, but to a lesser extent than in DVMs and DLMs. Anterior is to the left.
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stalled or aborted in the Mef2 knockdown animals, as we can judge
based on three major observations: 1) F-actin clearly accumulates in
Mef2 knockdown myoﬁbers; 2) the tissue-speciﬁc drivers, derived
from adult muscle actin genes, function effectively to suppress
MEF2 accumulation until the end of myogenesis, and therefore are
not dependent onMEF2 activity; and 3) quantitative RT-PCR analysis
did not reveal statistically signiﬁcant differences in Act88F expres-
sion levels between experimental and control samples at late time-
points of myogenesis (72 h and 90 h APF), even in aMef2 haploinsuf-
ﬁcient background and in a double-RNAi background. These data
provide further support for the notion that MEF2 is at most minimally
required for the sustained expression of some adult muscle genes.
Moreover, neither the Act88F nor the Act79B enhancers contain canon-
ical MEF2 binding sites (Andres et al., 1995), and neither enhancer is
activated by MEF2 in transient co-transfection assays (data not show).
In the light of the demonstrated independence of adult actin gene
transcription from Mef2 expression, one must ask how known MEF2-
dependent genes, with general muscle expression, respond to Mef2
silencing during adult myogenesis? In this study we used Mhc as an
example of such a pan-muscle-speciﬁc gene, since in the embryo ini-
tiation ofMhc expression depends onMef2 activity (Bour et al., 1995;
Lilly et al., 1995). In addition, the cloned minimal Mhc promoter/
enhancer contains three functional MEF2 sites (Hess et al., 2007;
Tanaka et al., 2008). Our data, however, indicate that MEF2 deple-
tion does not alter Mhc expression at statistically signiﬁcant levels,
even under exacerbated conditions. We conclude that while MEF2 is
required to initiate expression of Mhc, MEF2 is likely to be just one of
the factors participating in the maintenance of Mhc expression.
Our results are supported by the studies of others (Gajewski and
Schulz, 2010; Hess et al., 2007), in which the authors show that the
Mhc gene receives regulatory input from numerous evolutionarily
conserved cis-regulatory elements scattered throughout its complex
regulatory region, expanding from as far as 10-kb upstream of the
transcription start site and into the ﬁrst intron. Moreover, some of
the cloned Mhc enhancer elements, lacking MEF2 sites, directed
myoﬁber-speciﬁc reporter gene expression in adult ﬂies. Apparently,
maintenance of Mhc expression in adults depends on multiple
transcription factors.Besides Mhc, other pan-speciﬁcally expressed muscle genes have
been investigated for transcriptional regulatory elements. Tropomyosin-
1 and -2, Troponin T, and Paramyosin/mini-Paramyosin also possess
complex enhancers comprising multiple regulatory elements that
can be activated in a myoﬁbril-speciﬁc fashion, often independently
of MEF2 sites (Arredondo et al., 2001; Garcia-Zaragoza et al., 2008;
Lin and Storti, 1997; Marco-Ferreres et al., 2005). These, and other
observations (such as (Marin et al., 2004)), suggest that MEF2, while
being important for activation of muscle structural genes, becomes
less critical in their maintenance, which concurs with our observations.
The latter postulate can explain why enhancers containing generic
MEF2 sites, being functionally active in cell culture co-transfection
assays, fail to support muscle-speciﬁc expression of the LacZ reporter
gene in transgenic animals (data not shown); and why a single MEF2
site with ﬂanking sequences, taken out of the context of a functional
embryonic Act57B enhancer, is not capable of driving reporter gene
expression in embryonic muscles (Kelly et al., 2002).
Nevertheless, MEF2 remains a key regulator of early steps of myo-
genesis in Drosophila. According to our experimental data, MEF2 func-
tions in early stages of adult myogenesis to support myoblast fusion
and we postulate that at this time MEF2 also begins to activate addi-
tional muscle-speciﬁc regulatory factors that then go on to activate
muscle structural genes during the remainder of adult myogenesis.
So far, we are aware of very few factors, other than MEF2, that
directly regulate muscle structural genes in Drosophila. Chorion Factor-
2 (CF2) is an important MEF2 co-factor for muscle gene expression in
the embryo/larva (Tanaka et al., 2008), and it does play a role in adult
myogenesis as well (Gajewski and Schulz, 2010; Garcia-Zaragoza et al.,
2008). In addition, PAR-domain protein 1 (PDP1), with broad expression
in a range of tissues, was shown to speciﬁcally bind and activate the
enhancers of Tropomyosin-1 and mini-Paramyosin genes (Lin et al.,
1997b; Marco-Ferreres et al., 2005) cooperatively with MEF2 (Lin
et al., 1996; Lin et al., 1997b). The Cf2 gene is genetically downstream
ofMef2 (Bagni et al., 2002), while Pdp1 regulation is complicated due
to the presence of multiple alternative promoters, but late accumula-
tion of products of this gene in skeletal muscles during embryogene-
sis may suggest that it is also MEF2-dependent (Reddy et al., 2000).
Thus, MEF2 can be an initiator for expression of additional myogenic
regulators, and these factors can later acquire their own positive
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Fig. 10. RNAi knockdown of the actin gene Act88F in post-developed muscles does not
alter myoﬁbril morphology. A: Overlaid images of an enlarged area of the DLM in con-
trol and RNAi pupae at 72 h APF, stained for MEF2 (green), DNA (red), and F-actin
(gray); overlaid red and green signals produce yellow. The RNAi was induced by
Act88F–Gal4 driving the Act88F IR construct. In RNAi-induced DLM, myoﬁbrils are miss-
ing, demonstrating the effectiveness of the Act88F IR construct. B: Enlarged area of the
DLM stained for F-actin in control and RNAi ﬂies staged for 31 days at 29 °C. The adult-
speciﬁc RNAi was induced by the DJ694–Gal4 driver and the same Act88F IR construct.
Unlike the situation in the developing muscles, post-developed muscles in adults do
not produce a ﬁbrillar phenotype in response to actin silencing, even after a prolonged
exposure to RNAi targeting Act88F.
Table 3
Summary of phenotypes obtained with Mef2 IR constructs.
Mef2 IR
construct
Observed phenotype with 1151 driver
Stalled myoblast
fusion
Absent
muscles
Escaping
mini-muscles
Stalled activation of
Act88F and Mhc
IR2 Yes Yes Yes Not tested
IR5039 Yes Yes Yes Yes
Observed phenotype with Act79B driver
Reduced TDT
size
Disorganized
myoﬁbrils
Mis-shapen
ﬁbers
Perturbed nuclear
localization
IR2 Yes Yes Yes Yes
IR5039 Yes Yes Yes Yes
Observed phenotype with Act88F driver
Collapsed DLMs Disorganized
myoﬁbrils
Mis-shapen
nuclei
Continued expression
of Act88F and Mhc
IR2 Yes Yes Yes Not tested
IR5039 Yes Yes Yes Yes
IR2+
IR5039
Yes Yes Yes Yes
Observed phenotype with DJ694 driver
Shortened lifespan Weak ﬂier
IR2 No No
IR5039 Yes Not tested
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gial, participating in IFM development, is activated by MEF2 in adult-
speciﬁc myoblasts and then participates in self-activation (Bernard
et al., 2009). It is plausible that other transcriptional regulators par-
ticipating in myoﬁber-speciﬁc myogenesis ﬁrst receive activation of
their expression from MEF2 — to be later maintained by different
means.
Further, there is clearly a subset of muscle protein genes that are
activated after myoblast fusion and that must nevertheless be signif-
icantly affected by loss of MEF2 function. Evidence for this comes
from the pathology that does occur in Mef2-knockdown myoﬁbers,which includes loss of proper myoﬁbril organization, detachment of
muscle ﬁbers from the attachment sites, and separation of neighbor-
ing myoﬁbers. Some of theMef2-knockdown phenotypes were clearly
visible even after 18 h ofMef2 RNAi initiation (Fig. 8A), indicating that
there must be targets that are heavily dependent on MEF2 activity.
Identiﬁcation of such target genes should become a focus of future re-
search efforts.
The role of MEF2 in post-eclosion adult muscles
In the animals in which Mef2 knockdown was induced post eclo-
sion, we do not consider the severe changes in lifespan conferred by
the IR 5039 as being a true phenotype of MEF2 loss. Most likely, this
phenotype is a reﬂection of RNAi off-target activity. Thus, post-
eclosion, there appears to be relatively little requirement for MEF2,
at least over the time period and under the environmental conditions
that we have tested. This ﬁnding is consistent with the classical ob-
servations of Smith et al. (1970), who demonstrated that there is ex-
tremely low turnover of thoracic proteins following eclosion, and we
additionally demonstrate that sustained expression of Act88F is not
required following the ﬁrst day of adult life. We cannot rule out that
MEF2 may be participating in other aspects of muscle physiology, be-
sides structural protein turn-over. Hence, MEF2 might be involved in
expression of muscle-speciﬁc enzymes, controlling muscle metabo-
lism (Deak, 1977). Another intriguing possibility could be a potential
participation of MEF2 in muscle repair after an extensive muscle ex-
ercise such as long-term ﬂying, or pathology. The sustained presence
of MEF2 in mature adult muscles argues strongly for a role in these
cells, which additional studies should be designed to uncover.
Drosophila as a model for mammalian myogenesis
Vertebrate slow/fast twitch muscles consist of ﬁbers with different
functional, metabolic, and molecular properties (Zierath and Hawley,
2004), just as Drosophila adult muscles are ﬁne-tuned in order to
carry out their unique physiological functions. In both cases, it is
still unclear how initial ﬁber types are speciﬁed in the nascent muscle.
In mammals, there is evidence that ﬁber-type switching relies on
MEF2 working in combination with other transcription factors to
206 A.L. Bryantsev et al. / Developmental Biology 361 (2012) 191–207selectively activate muscle structural genes (Lin et al., 2002). Given
the broad conservation in the basic mechanisms of myogenesis, as
exempliﬁed by the role of MEF2 in muscle differentiation from ﬂies
to vertebrates, we anticipate that studying adult myogenesis in Dro-
sophila, which had been hindered by the lack of appropriate molec-
ular tools, now can start providing new genetic data on myoﬁber-
speciﬁc development.
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